Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | GPR35 | Q9HC97 | 6/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | TTR | P02766 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | GRM8 | O00222 | 1/20 | 0.44 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dinoseb SCHEMBL5933971 | 1.00 | TDP1 (0.61) | TDP1GPR35ALDH1A1KMT2AMEN1 | |
| Dinoseb SCHEMBL8534879 | 0.98 | TDP1 (0.62) | TDP1GPR35ALDH1A1KMT2AMEN1 | |
| Dinoseb SCHEMBL54664 | 0.98 | TDP1 (0.62) | TDP1GPR35ALDH1A1KMT2AMEN1 | |
| Dinoseb SCHEMBL29365762 | 0.98 | TDP1 (0.62) | TDP1GPR35ALDH1A1KMT2AMEN1 | |
| Dinoseb SCHEMBL9949230 | 0.97 | TDP1 (0.61) | TDP1GPR35ALDH1A1KMT2AMEN1 | |
| Dinoseb SCHEMBL11343942 | 0.92 | GPR35 (0.68) | TDP1GPR35ALDH1A1KMT2AMEN1 | |
| Dinoseb SCHEMBL11790365 | 0.89 | TDP1 (0.57) | TDP1GPR35ALDH1A1KMT2AMEN1 | |
| SCHEMBL11776456 | 0.89 | TDP1 (0.57) | TDP1GPR35ALDH1A1KMT2AMEN1 | |
| Dinoseb SCHEMBL5933953 | 0.88 | TDP1 (0.53) | TDP1GPR35ALDH1A1KMT2AMEN1 | |
| Dinoseb SCHEMBL31734134 | 0.88 | TDP1 (0.53) | TDP1GPR35ALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3060043-B1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | CORTEVA AGRISCIENCE LLC (US) | 2025-11-26 | — | — | EP | claimed |
| US-20230000079-A1 | COMBINATION COMPRISING A TRIKETONE HERBICIDE AND A DIPHENYLETHER HERBICIDE, AND A METHOD FOR MAKING AND USING THE COMBINATION | Generic Crop Science LLC (US) | 2023-01-05 | — | — | US | claimed |
| EP-3060043-B1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | CORTEVA AGRISCIENCE LLC (US) | 2025-11-26 | — | — | EP | disclosed |
| US-20250312364-A1 | METHODS FOR THE USE OF PSYCHEDELICS | TRYP THERAPEUTICS INC. (CA) | 2025-10-09 | — | — | US | disclosed |
| WO-2025052002-A1 | METHOD FOR HYDROXYLATION OF BILE ACIDS OR ANALOGUES THEREOF | Centrient Pharmaceuticals Netherlands B.V. (NL) | 2025-03-13 | — | — | WO | disclosed |
| US-20240307420-A1 | IMPROVED METHODS FOR THE USE OF PSYCHEDELICS | TRYP THERAPEUTICS INC. (CA) | 2024-09-19 | — | — | US | disclosed |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2024-04-04 | — | — | US | disclosed |
| US-11931452-B2 | Topical compositions containing rofecoxib and methods of making and using the same | JF PHARMA TECH LLC (US) | 2024-03-19 | — | — | US | disclosed |
| US-20240074995-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FIRST WAVE BIO, INC. | 2024-03-07 | — | — | US | disclosed |
| EP-4308128-A2 | IMPROVED METHODS FOR THE USE OF PSYCHEDELICS | Tryp Therapeutics Inc. (CA) | 2024-01-24 | — | — | EP | disclosed |
| EP-2970176-B1 | MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2023-10-25 | — | — | EP | disclosed |
| EP-4045480-A1 | PHARMACEUTICAL FORMULATIONS | First Wave Bio, Inc. (US) | 2022-08-24 | — | — | EP | disclosed |
| EP-3368542-B1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2022-06-22 | — | — | EP | disclosed |
| US-11357246-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2022-06-14 | — | — | US | disclosed |
| US-20220105057-A1 | METHODS OF TREATMENT | FIRST WAVE BIO, INC. | 2022-04-07 | — | — | US | disclosed |
| US-20220079897-A1 | METHODS OF TREATMENT | FIRST WAVE BIO, INC. | 2022-03-17 | — | — | US | disclosed |
| WO-2022051316-A1 | FIXED DOSE COMBINATIONS OF CHS-131 AND A SGLT-2 INHIBITOR | Coherus Biosciences, Inc. (US) | 2022-03-10 | — | — | WO | disclosed |
| WO-2022051323-A1 | FIXED DOSE COMBINATIONS OF CHS-131 AND A PPAR AGONIST | Coherus Biosciences, Inc. (US) | 2022-03-10 | — | — | WO | disclosed |
| WO-2022051318-A1 | FIXED DOSE COMBINATIONS OF CHS-131 AND A THYROID RECEPTOR BETA AGONIST | Coherus Biosciences, Inc. (US) | 2022-03-10 | — | — | WO | disclosed |
| US-11260023-B2 | Topical compositions containing rofecoxib and methods of making and using the same | BRIORI BIOTECH, LLC (US) | 2022-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230000079-A1 | COMBINATION COMPRISING A TRIKETONE HERBICIDE AND A DIPHENYLETHER HERBICIDE, AND A METHOD FOR MAKING AND USING THE COMBINATION | DDT, TDO2, DNTT | TDP1 289/4885GPR35 1908/4885ALDH1A1 960/4885 |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | TDP1 2650/4885GPR35 1513/4885ALDH1A1 978/4885 |
| US-20240074995-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FH, CS, ECHS1 | TDP1 1443/4885GPR35 535/4885ALDH1A1 2174/4885 |
| US-11357246-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | TDP1 2650/4885GPR35 1513/4885ALDH1A1 978/4885 |
| US-20220079897-A1 | METHODS OF TREATMENT | ACE2, ACE, SI | TDP1 3753/4885GPR35 354/4885ALDH1A1 3977/4885 |
| US-20220105057-A1 | METHODS OF TREATMENT | ACE2, ACE, SI | TDP1 3910/4885GPR35 428/4885ALDH1A1 3889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.